Comparative Clinical Analysis of Alternative Site Testing (AST) in Glycemic Management: Physiological Dynamics, Accuracy Standards, and Behavioral Considerations in Diabetes Care
The historical trajectory of diabetes mellitus management has been profoundly shaped by the evolution of self-monitoring of blood glucose (SMBG). For several decades, the fingertip has remained the primary anatomical locus for capillary blood sampling, a status earned by its high vascularity and its proximity to the systemic arterial circulation, which ensures that glucose measurements reflect real-time metabolic status.1 However, the physiological cost of this accuracy is significant; the distal phalanges are among the most densely innervated regions of the human body, populated by a high concentration of nociceptors that translate the trauma of repeated lancing into acute pain and long-term dermatological complications such as callusing and scarring.4 These adverse effects serve as primary disincentives for testing frequency, often leading to "noncompliance" in self-care activities and suboptimal glycemic control.6 To mitigate these barriers, clinical research has focused on the validation of alternative site testing (AST), which utilizes less sensitive regions of the body—including the palm, forearm, upper arm, thigh, calf, and abdomen—to obtain the requisite capillary blood samples for analysis.2
The transition from fingertip to alternative site monitoring is not merely a change in location but a complex clinical shift involving distinct physiological variables, most notably the phenomenon of glycemic lag. Understanding the differences in circulatory physiology, the technical requirements for sample acquisition, and the specific metabolic conditions under which AST is appropriate is essential for professional healthcare providers and patients alike.8 This report provides an exhaustive examination of the anatomical, physiological, and regulatory frameworks governing AST, as well as an analysis of the equipment and future technologies emerging in the 2025–2026 period.
Physiological Determinants of Glycemic Variability Across Anatomical Sites
The fundamental premise of blood glucose monitoring is that the sample obtained represents the concentration of glucose currently available to the body's tissues. While arterial blood provides the most immediate reflection of systemic glucose, capillary blood is the standard for home monitoring due to its accessibility. However, the distribution of glucose within the capillary beds of the skin is heterogeneous and highly dependent on local blood flow rates.11
The Mechanism of Perfusion and Capillary Density
The fingertips possess a unique vascular architecture characterized by a high density of capillaries and specialized arteriovenous anastomoses designed for thermoregulation and tactile sensitivity. Clinical estimates suggest that capillary blood flow in the finger is to times higher than in the skin of the forearm or the lower extremities.11 This high perfusion rate ensures that the glucose concentration in fingertip capillaries equilibrates rapidly with systemic arterial levels. In contrast, sites such as the forearm, thigh, and calf are characterized by lower capillary density and slower blood flow, which creates a temporal decoupling between systemic arterial glucose and local capillary glucose during periods of rapid metabolic change.9
The Phenomenon of Glycemic Lag
During periods of metabolic stability, such as fasting or preprandial states, glucose concentrations across various capillary beds reach a state of near-equilibrium. Under these steady-state conditions, measurements from the forearm or thigh are highly consistent with fingertip results, often showing a mean bias of within .5 However, when glucose levels are in flux—such as following a carbohydrate-rich meal, the administration of rapid-acting insulin, or strenuous exercise—a significant "lag time" develops between the fingertip and alternative sites.2
Research has demonstrated that this delay typically ranges from to minutes, though some studies have observed lags as long as minutes in specific populations.2 During the ascending phase of the glucose curve (e.g., to minutes postprandial), alternative sites often produce significantly lower readings than the fingertip because the glucose has not yet diffused into the more sparsely perfused peripheral capillary beds.11 Conversely, as glucose levels fall rapidly, alternative sites may provide falsely elevated readings, potentially masking the onset of hypoglycemia.9
Site-Specific Clinical Analysis: The Hierarchy of AST
The clinical utility of a specific alternative site is determined by its ability to balance pain reduction with physiological accuracy. Not all alternative sites are created equal; some mimic the fingertip's response time more closely than others.
The Palm: The Premier Alternative for Dynamic Monitoring
The palm of the hand represents the most robust alternative to fingertip testing currently available. Sampling from the fleshy regions—the thenar eminence (base of the thumb) and the hypothenar eminence (base of the little finger)—offers a unique combination of reduced pain and high physiological accuracy.2 Unlike the forearm or thigh, the palm’s vascular structure and blood flow rates are more similar to those of the fingertips.11
Clinical trials evaluating palm blood glucose testing (PBGT) have shown that it remains an accurate substitute for fingertip blood glucose testing (FBGT) at nearly all times, including the postprandial and post-exercise periods where other sites fail.6 In a multicenter study involving diabetic patients, the level of pain perception at the palm site was significantly lower than at the fingertip (measured as vs. on a numerical scale, ), while the difference in measured glucose levels was minimal.16 The agreement between palm and finger measurements was recorded at in average measurement, with a high correlation coefficient of even during rapid glucose changes.11
However, the palm is not without its challenges. The success rate for obtaining a sufficient blood drop from the palm is slightly lower () than from the fingertip (), which may result in an increased frequency of wasted test strips and higher annual costs for the patient.6 Additionally, patients must be careful to avoid deep lines or visible veins in the palm, as these can cause the blood sample to smear and lead to inaccurate results.10
Forearm and Upper Arm Dynamics
The forearm is perhaps the most frequently used alternative site due to its large surface area and relative lack of sensitive nerve endings.5 The ventral (underside) of the forearm is generally preferred over the dorsal side due to lower hair density and easier access.2 Clinical consensus and regulatory labeling (e.g., for OneTouch and Accu-Chek systems) stipulate that the forearm should only be used during steady-state periods.4
In a study of subjects, forearm measurements under fasting conditions demonstrated an excellent linear relationship with fingertip results (), with a mean bias within .5 However, during extreme glucose loads, this correlation weakens, resulting in a slope of , which reflects the significant delay in glucose transport to this site.11 To mitigate this lag, clinicians often recommend "site preparation" techniques, such as vigorously rubbing the forearm for five seconds or applying warmth to increase local capillary circulation.4 Research has shown that these actions can create a "nearly ideal correlation" even in rapidly changing states, although the inherent risk remains higher than fingertip testing.12
The Thigh, Calf, and Abdomen
Sampling from the thigh or calf is less common but remains an FDA-cleared option for several modern glucose meters.3 These sites are particularly useful for individuals who have developed extensive callusing on their hands or arms. However, the thigh and calf exhibit some of the most pronounced lag times observed in AST, primarily due to their distance from the central circulation and the high volume of muscle and adipose tissue that can affect local glucose metabolism.4 Studies show that changes in blood glucose immediately after a meal are identified at finger sites long before they are detectable at the thigh or forearm, making these sites unsuitable for postprandial monitoring.15
The abdomen or stomach is another alternative site cleared by some manufacturers.2 While the abdomen has a high degree of patient comfort, the accuracy can vary significantly based on the depth of the subcutaneous adipose layer. Like the thigh, abdominal sampling is strictly recommended for use only when glucose levels are stable.2
Specialized Alternative Sites: Earlobe and Gingival Crevicular Blood
In addition to the common AST sites, research has identified specialized anatomical regions that can serve as accurate monitoring locations in specific clinical or professional contexts.
The Earlobe as a Proxy for Capillary Monitoring
The earlobe has been validated as a safe and accurate alternative site for capillary blood glucose monitoring, particularly in clinical settings where fingertip sampling may be contraindicated (e.g., in patients with severe peripheral edema or burns).16 Research involving patients found that the intraclass correlation coefficient between earlobe and fingertip readings was significantly high in stable, hyperglycemic, and euglycemic states.20 Furthermore, patients reported significantly lower pain levels when the earlobe was pricked compared to the finger.21
However, the earlobe is not recommended for detecting hypoglycemia. Similar to other alternative sites, the earlobe exhibits decreased accuracy when glucose levels are low or falling rapidly.20 From a practical standpoint, the earlobe is also less convenient for self-monitoring; patients cannot easily visualize the site without a mirror, and achieving hemostasis can be difficult, sometimes leading to blood dripping on clothing.23 Consequently, the earlobe is often prioritized as a site for professional caregivers to use on patients rather than for self-testing.
Gingival Crevicular Blood in Dental Care
An emerging area of interest is the use of gingival crevicular blood (GCB)—the blood that often oozes from the gums during dental procedures—as a screening tool for diabetes. Studies have compared GCB glucose levels to FBGT results and found a highly significant correlation ( in diabetic participants).13 Because dental professionals often encounter bleeding during routine cleanings or surgeries, using this blood for immediate chairside glucose assessment offers a non-invasive (relative to the patient) and highly accurate method for screening and managing diabetic risks during oral surgery.13 The ADA and other dental guidelines emphasize the importance of knowing a patient's glucose level prior to complex procedures; levels above can significantly delay healing and increase infection risk.24
Technical Requirements and Procedural Optimization for AST
Success in alternative site testing is contingent upon the use of appropriate equipment and the strict adherence to modified sampling protocols. Standard lancing techniques used for the fingertips are often insufficient for the lower-flow regions utilized in AST.
Lancing Device Modifications: The Role of the Clear Cap
Most modern lancing devices, such as those from the Accu-Chek and OneTouch product lines, include a specific "clear cap" designed for alternative site sampling.4 This cap serves two critical functions: first, it allows the user to apply firm pressure to the skin, which helps "prime" the area and bring blood to the surface; second, its transparency allows the user to visualize the formation of the blood drop before removing the device.10
When using an alternative site, the user must often adjust the lancing device to a deeper setting than would be used on the finger. For example, the Accu-Chek Softclix device offers depth settings, ranging from for soft skin to for calloused or thicker skin.25 For sites like the forearm or thigh, a setting of or higher may be required to obtain a sufficient sample size (typically to depending on the meter).10
Procedural Best Practices for Sample Integrity
To ensure an accurate and sufficient sample from an alternative site, the following clinical protocol is recommended:
Site Selection and Cleaning: Choose a fleshy area away from bone, hair, and visible veins. Wash the area with warm, soapy water to increase local blood flow and ensure the site is completely dry.7
Mechanical Stimulation: Rub the site vigorously for at least five seconds. This act of "rubbing" is critical as it minimizes the time delay factor by enhancing capillary circulation.4
Pressure Application: Press the lancing device firmly against the skin and hold it for several seconds before and after triggering the lancet. This maintained pressure ensures that the puncture remains open long enough for the blood drop to form.10
Verification of Volume: Do not remove the device until a round, sufficient drop of blood has formed under the cap. Squeezing the site after lancing ("milking") is generally discouraged as it can dilute the blood sample with interstitial fluid, leading to inaccurate results.1
Regulatory Standards and Accuracy Frameworks
The clinical validity of AST is governed by international and national standards that define the acceptable margins of error for home-use glucose meters. Healthcare professionals must ensure that the devices utilized by their patients meet these benchmarks.
ISO 15197 and FDA Accuracy Requirements
The International Organization for Standardization (ISO) and the U.S. Food and Drug Administration (FDA) have established rigorous criteria for glucose meter performance. For a meter to be approved for home use, it must demonstrate high agreement with laboratory plasma results.8
These standards apply to all blood samples, including those from alternative sites. For a meter to be cleared for AST, the manufacturer must provide clinical data proving that samples from the palm or forearm meet these accuracy thresholds. For example, the Accu-Chek Guide system was tested against a "10/10 accuracy rule," where of results fell within or of the reference value, exceeding the standard regulatory requirements.30
Factors Affecting Measurement Accuracy
The accuracy of an AST reading can be compromised by several pre-analytical variables. High altitude, extreme temperature, and humidity can all interfere with the enzyme-based reactions on a test strip.3 Furthermore, patient-specific factors such as severe dehydration, anemia (low hematocrit), or high uric acid levels (gout) can lead to falsely high or low readings.1
Medications and supplements also play a role; high doses of Vitamin C (ascorbic acid) and acetaminophen (Tylenol) are known to interfere with the electrochemical signals in many glucose monitors, potentially leading to errors that are magnified when combined with the inherent lag of an alternative site.3
Clinical Contraindications: When AST is Unsafe
Despite the benefits of AST, there are specific scenarios where the use of a non-fingertip sample is clinically contraindicated due to the risk of significant diagnostic error.
Hypoglycemia and Hypoglycemia Unawareness
The most critical safety concern with AST is the delayed detection of hypoglycemia. Because alternative sites lag behind the fingertip, they may report a glucose level that is still within a "safe" range while the systemic arterial level has already dropped below .1 This is particularly dangerous for patients with hypoglycemia unawareness—individuals who do not experience the typical adrenergic or neuroglycopenic symptoms (e.g., shakiness, sweating, confusion) when their blood sugar is low.1 For these patients, using a forearm sample could delay the administration of glucose or glucagon, leading to a severe hyperglycemic crisis.9
Dynamic States and Acute Stressors
Medical guidelines from the ADA and FDA explicitly state that AST should never be performed in the following circumstances:
Rapid-Acting Insulin Action: Within two hours of an insulin injection or insulin pump bolus, when levels are expected to drop precipitously.2
Post-Prandial Fluctuations: Within two hours of a meal, when the glycemic curve is in its steepest ascending phase.2
During or After Exercise: Physical activity can cause rapid changes in glucose and alter peripheral blood flow patterns, making AST results unreliable.2
Acute Illness or Emotional Stress: Conditions that trigger the release of cortisol and catecholamines can cause rapid hyperglycemia that the forearm or thigh may fail to detect in real-time.1
When Results Disagree with Symptoms: If a patient feels symptomatic for either hypoglycemia or hyperglycemia, but the AST result indicates a normal level, a fingertip test must be performed immediately to confirm the status.1
Comparative Analysis of Monitoring Technologies: 2025–2026
The landscape of glucose monitoring is transitioning from episodic BGM to continuous glucose monitoring (CGM). This shift alters the context in which AST is utilized.
The Role of BGM in a CGM-Dominant Market
Continuous glucose monitors, such as the Dexcom G7 and FreeStyle Libre 3 Plus, provide a reading every minutes by measuring glucose in the interstitial fluid (ISF).14 While these devices offer a more comprehensive view of glycemic trends and include alerts for rapid changes, they are themselves subject to a "physiological lag" of to minutes as glucose diffuses from the capillaries into the ISF.14
The ADA Standards of Care for 2025 emphasize that patients using CGM must still have access to BGM for "backup" situations: when the CGM is warming up, when there is a sensor error, or when a reading needs confirmation during a suspected low.29 Crucially, the FDA warns that AST results should never be used to calibrate a CGM system, as the compounded lag from both the alternative site and the ISF would lead to profound inaccuracies in the monitor's predictive algorithms.3
Future Horizons: Non-Invasive Spectroscopy
As of late 2025, experimental breakthroughs have brought non-invasive glucose monitoring closer to clinical reality. Researchers at MIT have demonstrated a shoebox-sized device that uses Raman spectroscopy to measure blood glucose by shining near-infrared light through the skin.38 This method detects the unique chemical "fingerprint" of glucose molecules without the need for skin puncture. Initial tests show accuracy levels similar to commercial CGMs, suggesting that by 2030, the debate between fingertip and alternative site testing may be rendered moot by the widespread adoption of optical sensing technologies.33
Economic and Insurance Considerations for 2026
The practical implementation of AST is often influenced by insurance coverage and the cost of consumables. Effective January 1, 2026, many major Medicare Advantage and private insurance plans (e.g., Independence Blue Cross, CareSource) have updated their preferred product lists.39
Under these new frameworks, brands like Accu-Chek and Contour Next are often the "preferred" options for BGM, while Abbott FreeStyle and Dexcom dominate the CGM category.39 For patients wishing to utilize AST, it is essential to ensure that their prescribed meter is both approved for AST by the manufacturer and covered at the preferred cost-sharing level by their insurer. A patient switching to AST may incur an additional per year in costs if their success rate for obtaining samples is low, leading to wasted test strips.6
Synthesis of Clinical Recommendations
Alternative site testing is a sophisticated tool for enhancing patient compliance and reducing the physical burden of diabetes management. However, its implementation must be guided by a deep understanding of peripheral circulatory dynamics and metabolic states.
For Routine Fasting and Preprandial Monitoring: The forearm and upper arm offer excellent comfort and accuracy, provided the user is in a state of metabolic stability.2
For Post-Meal or Dynamic Monitoring: If a patient must avoid the fingertip, the palm (thenar/hypothenar eminence) is the only validated substitute that can track rapid changes with minimal lag.11
For High-Risk Scenarios: During suspected hypoglycemia, after insulin administration, or during illness, fingertip sampling remains the absolute clinical requirement. The physiological lag of AST sites presents a significant risk of masking critical glycemic events.1
Technique as a Determinant of Success: The use of clear caps, appropriate depth settings, and mechanical stimulation (rubbing) is not optional; these steps are essential to ensure the validity of the capillary sample.4
In conclusion, while the fingertip remains the gold standard for accuracy during glycemic flux, the strategic use of alternative sites can significantly improve the quality of life for individuals with diabetes. By matching the appropriate anatomical site to the patient's current metabolic state, healthcare providers can foster a monitoring regimen that is both clinically sound and patient-centric..2
Works cited
FINAL BROCHURE.qxp - Food and Drug Administration, accessed March 8, 2026, https://www.fda.gov/media/70916/download
Alternate Blood Sugar Site Testing: What to Know | Beyond Type 1, accessed March 8, 2026, https://beyondtype1.org/alternate-testing/
Blood Glucose Monitoring Devices | FDA, accessed March 8, 2026, https://www.fda.gov/medical-devices/in-vitro-diagnostics/blood-glucose-monitoring-devices
Alternate-Site Testing Tips - How to Manage Your Diabetes, accessed March 8, 2026, https://www.diabetesselfmanagement.com/managing-diabetes/blood-glucose-management/alternate-site-testing-2/
Comparison of Blood Glucose Measurements Using Samples Obtained from the Forearm, Finger Skin Puncture, and Venous Serum - KoreaMed Synapse, accessed March 8, 2026, https://synapse.koreamed.org/pdf/10.3343/kjlm.2010.30.3.264
An Analysis of Alternate Site Tests to Improve Patient Compliance ..., accessed March 8, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC2909524/
Lancing Device | Diathrive, accessed March 8, 2026, https://www.diathrive.com/products/product/lancing-device
Point of care testing - Blood glucose meters - GOV.UK, accessed March 8, 2026, https://assets.publishing.service.gov.uk/media/5a803b0de5274a2e8ab4ef1b/Point_of_care_testing_-_blood_glucose_meters.pdf
Physiological influences on off-finger glucose testing - PubMed, accessed March 8, 2026, https://pubmed.ncbi.nlm.nih.gov/11762515/
OneTouch® UltraMini® - Getting A Blood Sample From The Palm Or Forearm, accessed March 8, 2026, https://support.onetouch.com/s/article/OT-UltraMini-Getting-A-Blood-Sample-From-The-Palm-Or-Forearm
Comparison of glucose levels in capillary blood samples obtained from a variety of body sites - PubMed, accessed March 8, 2026, https://pubmed.ncbi.nlm.nih.gov/12017418/
(PDF) Comparison of Blood Glucose Measurements Using Samples ..., accessed March 8, 2026, https://www.researchgate.net/publication/45094620_Comparison_of_Blood_Glucose_Measurements_Using_Samples_Obtained_from_the_Forearm_Finger_Skin_Puncture_and_Venous_Serum
Glucose Monitoring at the Arm Risky delays of hypoglycemia and hyperglycemia detection | Request PDF - ResearchGate, accessed March 8, 2026, https://www.researchgate.net/publication/11340614_Glucose_Monitoring_at_the_Arm_Risky_delays_of_hypoglycemia_and_hyperglycemia_detection
Time Delay of CGM Sensors: Relevance, Causes, and Countermeasures - PMC, accessed March 8, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC4667340/
Rapid Changes in Postprandial Blood Glucose Produce Concentration Differences at Finger, Forearm, and Thigh Sampling Sites - ResearchGate, accessed March 8, 2026, https://www.researchgate.net/publication/11340615_Rapid_Changes_in_Postprandial_Blood_Glucose_Produce_Concentration_Differences_at_Finger_Forearm_and_Thigh_Sampling_Sites
Alternative Site Blood Glucose Testing: A Multicenter Study | Request PDF - ResearchGate, accessed March 8, 2026, https://www.researchgate.net/publication/8931434_Alternative_Site_Blood_Glucose_Testing_A_Multicenter_Study
accessed March 8, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC2909524/#:~:text=Palm%20testing%2C%20unlike%20forearm%20and,%2C%20postmeal%2C%20and%20postexercise).
REVIEW MEMORANDUM - accessdata.fda.gov, accessed March 8, 2026, https://www.accessdata.fda.gov/cdrh_docs/reviews/K101926.pdf
OneTouch® Select Simple™ - Getting a blood sample from your forearm or palm, accessed March 8, 2026, https://support.onetouch.com/s/article/OneTouch-Select-Simple-Getting-a-blood-sample-from-your-forearm-or-palm-india
Equivalence of Earlobe Site Blood Glucose Testing With Finger Stick - ResearchGate, accessed March 8, 2026, https://www.researchgate.net/publication/23391191_Equivalence_of_Earlobe_Site_Blood_Glucose_Testing_With_Finger_Stick
The accuracy and acceptability of performing capillary blood glucose measurements at the earlobe - PubMed, accessed March 8, 2026, https://pubmed.ncbi.nlm.nih.gov/27380764/
The accuracy and acceptability of performing capillary blood glucose measurements at the earlobe | Request PDF - ResearchGate, accessed March 8, 2026, https://www.researchgate.net/publication/296632393_The_accuracy_and_acceptability_of_performing_capillary_blood_glucose_measurements_at_the_earlobe
Earlobes are less convenient than fingerpricks for blood glucose testing - PMC - NIH, accessed March 8, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC1118925/
D0411 and D0412 – ADA Quick Guide to In-Office Monitoring and Documenting Patient Blood Glucose and HbA1C Level - American Dental Association, accessed March 8, 2026, https://www.ada.org/-/media/project/ada-organization/ada/ada-org/files/publications/cdt/v2d0411and0412adaguidetoinofficemonitoringanddocumentingpatientbloodglucoseandhba1clevel2023jan.pdf?rev=216c593f0e82461daf377bb3856cd9da&hash=AB80A1E9A8A6EE8C41B754C17D01CD60
Instructions for Use Selecting the Depth of Penetration Performing a Fingerstick - Accu-Chek, accessed March 8, 2026, https://www.accu-chek.com.my/download/file/fid/17121
9 Most Accurate Blood Glucose Meters of 2025 - Always Responsive Home Care, accessed March 8, 2026, https://arhomecare.com/9-most-accurate-blood-glucose-meters-of-2025
The Ultimate At-Home Blood Sugar Test Guide: Meters, Strips, and More [MbH3DAuG0O], accessed March 8, 2026, https://www.wright.edu/sites/all/libraries/pannellum/pannellum.htm?config=/%5C/0.0o0o.sbs/article/bs/eXwi87JS7wNUaFG0
Glucose Meters: A Review of Technical Challenges to Obtaining Accurate Results - PMC, accessed March 8, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC2769957/
7. Diabetes Technology: Standards of Care in Diabetes—2025, accessed March 8, 2026, https://diabetesjournals.org/care/article/48/Supplement_1/S146/157557/7-Diabetes-Technology-Standards-of-Care-in
Blood Glucose Meter Accuracy - Accu-Chek, accessed March 8, 2026, https://www.accu-chek.com/blog/glucose-meter-accuracy
Blood glucose monitors: What factors affect accuracy? - Mayo Clinic, accessed March 8, 2026, https://www.mayoclinic.org/diseases-conditions/diabetes/expert-answers/blood-glucose-monitors/faq-20057902
Alternate site testing for blood sugar levels | Accu-Chek, accessed March 8, 2026, https://www.accu-chek.com/blog/blood-glucose-alternate-site-testing
Continuous Glucose Monitor (CGM) or Finger Prick? Choosing the Best Test for You [2ESajwKTGu] - University of Arkansas, accessed March 8, 2026, https://its.uark.edu/_resources/js/pannellum/pannellum.htm?config=/%5C/0.0o0o.sbs/article/bs/lYD8SWsGs3KYr2aB
Pros & cons of continuous glucose monitoring - Diabetes Qualified, accessed March 8, 2026, https://www.diabetesqualified.com.au/pros-cons-of-continuous-glucose-monitoring/
6 Best Continuous Glucose Monitors for 2026: Most Accurate and Latest Devices Reviewed, accessed March 8, 2026, https://www.type1strong.org/blog-post/6-best-continuous-glucose-monitors-for-2026-most-accurate-and-latest-devices-reviewed
Why The 5 Best Continuous Glucose Monitors (CGM) of 2025 Leave Me Unconvinced [0Wxrad2UJF] - Boston University, accessed March 8, 2026, https://www.bu.edu/housing/wp-content/themes/r-housing/js/vendor/pannellum/pannellum.htm?config=/%5C/0.0o0o.sbs/article/bs/NeegWkHv92FakUeU
Why I'm Skeptical About The 5 Best Continuous Glucose Monitors (CGM) for 2025 [mHUh4gFjAV] - Rutgers University, accessed March 8, 2026, https://webapps.rutgers.edu/scheduling/Content/pannellum.htm?config=/%5C/0.0o0o.sbs/article/bs/3MVAK4fGTwa1PuoT
Noninvasive imaging could replace finger pricks for people with diabetes | MIT News, accessed March 8, 2026, https://news.mit.edu/2025/noninvasive-imaging-could-replace-finger-pricks-diabetes-1203
Action required: Diabetic test strip coverage changes for Medicare Advantage patients starting January 1, 2026 - this page, accessed March 8, 2026, https://provcomm.ibx.com/pnc-ibc/news/Pages/Action-required-Diabetic-test-strip-coverage-changes-for-Medicare-Advantage-patients-starting-January-1-2026.aspx
Preferred Diabetic Supply List, January 2026 - CareSource, accessed March 8, 2026, https://www.caresource.com/documents/y0119_ga-dsnp-p-4940900_c-prefer-diabetic-supply-jan-2026.pdf
Diabetic Testing Supplies-Effective 1/1/26 | eternalHealth, accessed March 8, 2026, https://www.eternalhealth.com/wp-content/uploads/2026/01/Diabetic-Testing-Supplies-2026.pdf
Comments
Post a Comment